Mary Wilson
Well-known member
09:23, 20 November 2021
Source : 112 Ukraine
Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not need oxygen support and are at risk of severe disease.
The European Medicines Agency (EMA) has advised its member states they can use a potentially groundbreaking Covid-19 antiviral pill in emergency situations. This was reported by the press service of the EMA.
Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not need oxygen support and are at risk of severe disease.
The EMA said it had issued its advice to support national authorities who may be keen to deploy the pill, to be branded Lagevrio in Europe, ahead of it gaining full authoristation from the regulator ...
https://112.international/society/e...ks-covid-19-pill-for-emergency-use-67017.html
Source : 112 Ukraine
Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not need oxygen support and are at risk of severe disease.
The European Medicines Agency (EMA) has advised its member states they can use a potentially groundbreaking Covid-19 antiviral pill in emergency situations. This was reported by the press service of the EMA.
Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not need oxygen support and are at risk of severe disease.
The EMA said it had issued its advice to support national authorities who may be keen to deploy the pill, to be branded Lagevrio in Europe, ahead of it gaining full authoristation from the regulator ...
https://112.international/society/e...ks-covid-19-pill-for-emergency-use-67017.html
